Does VIBEGRON Cause Neoplasm malignant? 32 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Neoplasm malignant have been filed in association with VIBEGRON (GEMTESA). This represents 0.7% of all adverse event reports for VIBEGRON.
32
Reports of Neoplasm malignant with VIBEGRON
0.7%
of all VIBEGRON reports
14
Deaths
2
Hospitalizations
How Dangerous Is Neoplasm malignant From VIBEGRON?
Of the 32 reports, 14 (43.8%) resulted in death, 2 (6.3%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VIBEGRON. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does VIBEGRON Cause?
Drug ineffective (732)
Inability to afford medication (267)
Urinary retention (223)
Headache (218)
Diarrhoea (215)
Urinary tract infection (184)
Pollakiuria (171)
Therapeutic product effect incomplete (167)
Urinary incontinence (166)
Product availability issue (164)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which VIBEGRON Alternatives Have Lower Neoplasm malignant Risk?
VIBEGRON vs VICODIN
VIBEGRON vs VICTOZA
VIBEGRON vs VICTRELIS
VIBEGRON vs VIDAZA
VIBEGRON vs VIGABATRIN